ARCHIVES

FDA Should Delay Provenge Decision Pending Definitive Trial Results, ODAC Chairman Writes.

This article is from The Cancer Letter archive.

Vol. 33 No. 16 | April 27, 2007

Download PDF Visit The Full Archive

Related Articles

In Brief: NCCR Presents Gold Medal To Sen. Karkin; DCT Recruits Okunieff For Radiation Oncology

February 26, 1993

Phase III Trial: Panobinostat Increases PFS by Four Months

September 26, 2014

FDA Approves Bayer’s Xofigo For Late-Stage Prostate Cancer

May 31, 2013

Sanding Study Section For Cancer Control Grants Needed, Board Says

May 17, 1985

DCE Concepts Statements

March 11, 1988

NCI To Offer New Grants In Preventative Oncology -Epidemiology, Biostatistics

October 26, 1979